Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction

Saman Rasoul1, Mark B Nienhuis, Jan Paul Ottervanger

  • 1Isala Klinieken, Locatie Weezenlanden, Department of Cardiology, Groot Wezenland 20, 8011 JW Zwolle, The Netherlands.

Insights

Elevated cardiac troponin T (cTnT) in ST-segment elevation myocardial infarction (STEMI) is common, even with early treatment. Presentation delay, older age, and anterior MI location independently predict higher cTnT levels.

Area of Science:

  • Cardiology
  • Biomarkers
  • Acute Myocardial Infarction

Background:

  • Elevated cardiac troponin T (cTnT) in ST-segment elevation acute myocardial infarction (STEMI) correlates with adverse outcomes.
  • Presentation delay is a suspected primary driver of elevated admission cTnT levels.

Purpose of the Study:

  • To investigate presentation delay and other factors predicting elevated cTnT on admission in STEMI patients undergoing primary percutaneous coronary intervention (PCI).

Main Methods:

  • Cardiac troponin T (cTnT) was measured on arrival in 444 STEMI patients undergoing primary PCI.
  • An elevated cTnT level was defined as > 0.05 microg/L.

Main Results:

  • Nearly 50% of patients had elevated admission cTnT.
  • Elevated cTnT was associated with less successful primary PCI and higher one-year mortality.
  • Presentation delay, anterior myocardial infarction (MI) location, and older age were independent predictors of elevated admission cTnT.

Conclusions:

  • A significant proportion of STEMI patients present with elevated cTnT, irrespective of presentation time.
  • Early presentation does not preclude elevated cTnT levels.
  • Presentation delay, increasing age, and anterior MI location are key independent predictors of elevated admission cTnT.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...